{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:22:23Z","timestamp":1792416143904,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bone.2021.116077","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:00:19Z","timestamp":1624597219000},"page":"116077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Tumor induced osteomalacia: A single center experience on 17 patients"],"prefix":"10.1016","volume":"152","author":[{"given":"C.","family":"Crotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Coletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Daolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parafioriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Armiraglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sinigaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-0909","authenticated-orcid":false,"given":"M.","family":"Varenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0010","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116077_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","article-title":"Tumor-induced osteomalacia: a single center experience","volume":"17","author":"Jagtap","year":"2011","journal-title":"Endocr. Pract."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr. J."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/1346-8138.12602","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work","volume":"41","author":"Honda","year":"2014","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.bone.2021.116077_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Yin","year":"2018","journal-title":"Osteoporos. Sarcopenia"},{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","article-title":"A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets","volume":"19","author":"Jung","year":"2010","journal-title":"J. Pediatr. Orthop. B"},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","article-title":"Tumor-induced osteomalacia","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"10","key":"10.1016\/j.bone.2021.116077_bb0050","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bone.2021.116077_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","article-title":"The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23","volume":"27","author":"White","year":"2006","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.bone.2021.116077_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.bone.2021.116077_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","article-title":"Reports of 17 Chinese patients with tumor-induced osteomalacia","volume":"35","author":"Yu","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2021.116077_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep."},{"issue":"Pt 6","key":"10.1016\/j.bone.2021.116077_bb0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0004563214521399","article-title":"Phosphate homeostasis and disorders","volume":"51","author":"Manghat","year":"2014","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0085","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00428-005-0149-2","article-title":"Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis","volume":"448","author":"Shelekhova","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bone.2021.116077_bb0095","doi-asserted-by":"crossref","unstructured":"Kominek P, Starek I, Geierova M, Matousek P, Zelenik K. Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature. Head Neck Oncol. Mar 16 2011;3:16. Epub 2011\/03\/18.","DOI":"10.1186\/1758-3284-3-16"},{"issue":"10","key":"10.1016\/j.bone.2021.116077_bb0100","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","article-title":"Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.116077_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.bone.2021.116077_bb0110","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.bone.2021.116077_bb0115","first-page":"1922","article-title":"Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification","volume":"56","author":"Reubi","year":"1996","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin. Nucl. Med."},{"issue":"12","key":"10.1016\/j.bone.2021.116077_bb0125","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","article-title":"The importance of whole body imaging in tumor-induced osteomalacia","volume":"96","author":"Chong","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116077_bb0130","article-title":"Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET\/CT, venous sampling and 3T-MRI","volume":"2017","author":"Kawai","year":"2017","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"10","key":"10.1016\/j.bone.2021.116077_bb0135","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijom.2018.02.008","article-title":"Maxillary tumour-induced osteomalacia","volume":"47","author":"Emodi","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"10","key":"10.1016\/j.bone.2021.116077_bb0140","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0145","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2013-4515","article-title":"Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients","volume":"99","author":"Jadhav","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2021.116077_bb0150","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1210\/jc.2012-1719","article-title":"Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation","volume":"97","author":"Tutton","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2021.116077_bb0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jbspin.2015.09.011","article-title":"Osteomalacia by a mesenchymal-FGF23-producing tumour: successful treatment with radiofrequency ablation. A case report","volume":"83","author":"Igney-Oertel","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"11","key":"10.1016\/j.bone.2021.116077_bb0160","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jbmr.3219","article-title":"Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia","volume":"32","author":"Tella","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116077_bb0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4613-4217-5_44","article-title":"The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia","volume":"81","author":"Peacock","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116077_bb0175","doi-asserted-by":"crossref","unstructured":"Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, et al. Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res. Dec 18 2020.","DOI":"10.1002\/jbmr.4233"},{"issue":"7929","key":"10.1016\/j.bone.2021.116077_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0190","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116077_bb0195","series-title":"Soft Tissue and Bone Tumours","first-page":"284","article-title":"Phosphaturic mesenchymal tumour","volume":"3","author":"Lee","year":"2020"},{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.116077_bb0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/his.13377","article-title":"Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant","volume":"72","author":"Yamada","year":"2018","journal-title":"Histopathology."},{"issue":"4","key":"10.1016\/j.bone.2021.116077_bb0210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cncr.30370","article-title":"Needle tract seeding after percutaneous biopsy of sarcoma: risk\/benefit considerations","volume":"123","author":"Berger-Richardson","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bone.2021.116077_bb0215","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archsurg.139.6.634","article-title":"Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer","volume":"139","author":"Hansen","year":"2004","journal-title":"Arch. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.116077_bb0220","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.bone.2021.116077_bb0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ckj\/sfu004","article-title":"Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level","volume":"7","author":"Amblee","year":"2014","journal-title":"Clin. Kidney J."},{"issue":"8","key":"10.1016\/j.bone.2021.116077_bb0230","first-page":"9422","article-title":"Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors","volume":"8","author":"Tajima","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.bone.2021.116077_bb0235","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/modpathol.3800084","article-title":"Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia","volume":"17","author":"Toyosawa","year":"2004","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.bone.2021.116077_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-016-1187-z","article-title":"\u201cSlow and steady wins the race\u201d: the importance of perseverance in the management of oncogenic osteomalacia","volume":"57","author":"Manara","year":"2017","journal-title":"Endocrine."},{"key":"10.1016\/j.bone.2021.116077_bb0250","doi-asserted-by":"crossref","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, et al. Tumour-induced osteomalacia. Nat Rev Dis Primers. Jul 13 2017;3:17044.","DOI":"10.1038\/nrdp.2017.44"},{"issue":"4","key":"10.1016\/j.bone.2021.116077_bb0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00223-009-9275-1","article-title":"Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases","volume":"85","author":"Rendina","year":"2009","journal-title":"Calcif. Tissue Int."},{"issue":"13","key":"10.1016\/j.bone.2021.116077_bb0260","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"issue":"9","key":"10.1016\/j.bone.2021.116077_bb0265","first-page":"1158","article-title":"Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets\/osteomalacia","volume":"123","author":"Xia","year":"2010","journal-title":"Chin. Med. J."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:58:39Z","timestamp":1757613519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"alternative-id":["S8756328221002398"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116077","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor induced osteomalacia: A single center experience on 17 patients","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116077"}}